[Whitepaper] Enhancing Productivity in Drug Discovery: Removing Inefficiencies and Distractions Caused by Chemicals and Biologics Management

The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D.

Download the whitepaper.


Sponsored by: